Author

M. Dey

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2 Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

I. T. Ozbolat· 3 shared D. Unutmaz· 2 shared L. Kozhaya· 2 shared M. Dogan· 2 shared M. H. Kim· 2 shared M. Nagamine· 2 shared A. Geethadevi· 1 shared A. U. Ahmed· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBioengineering

I. T. Ozbolat

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

3D Bioprinted perfusable and vascularized breast tumor model for dynamic screening of chemotherapeutics and CAR-T cells

M. Dey, M. H. Kim, M. Nagamine, M. Dogan, L. Kozhaya, D. Unutmaz, I. T. Ozbolat

This paper develops a 3D bioprinted vascularized breast tumor model to dynamically screen chemotherapeutics and CAR-T cells, showing dose-dependent drug response and significant tumor reduction with CAR-T treatment.

bioRxiv · Mar 15, 2022 · PreprintBioengineering

Development of 3D breast cancer models with human T cells expressing engineered MAIT cell receptors

M. Dey, M. H. Kim, M. Nagamine, E. Karhan, L. Kozhaya, M. Dogan, D. Unutmaz, I. T. Ozbolat

This study develops 3D breast cancer models with engineered MAIT cell receptors to assess their cytotoxic activity against tumor cells.

bioRxiv · Jan 29, 2022 · PreprintImmunology

RNA-binding protein FXR1 drives cMYC translation by mRNA circularization through eIF4F recruitment in ovarian cancer

J. George, Y. Li, D. Parashar, S.-W. Tsaih, P. Gupta, A. Geethadevi, I. Kadembari, C. Ghosh, Y. Sun, R. Ramchandran, J. S. Rader, H. Rui, M. Dey, S. Pradeep, P. Chaluvally-Raghavan

This study identifies FXR1 as a driver of cMYC translation through mRNA circularization and eIF4F recruitment in ovarian cancer, linking FXR1 amplification to poor prognosis.

bioRxiv · Jul 19, 2020 · PreprintCancer Biology

3D bioprinting of co-cultured osteogenic spheroids for bone tissue fabrication

D. Heo, B. Ayan, M. Dey, D. Banerjee, G. Lewis, H. Wee, I. T. Ozbolat

This paper develops a 3D bioprinting method using co-cultured spheroids to create scaffold-free bone tissue constructs with improved osteogenic differentiation and cell viability.

bioRxiv · Jun 16, 2020Bioengineering

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma

T. Hasan, S. P. Caragher, J. M. Shireman, C. H. Park, F. Atashi, S. Baisiwala, G. Lee, D. Guo, M. Wu, J. Y. Wang, M. Dey, M. S. Lesniak, C. M. Horbinski, C. D. James, A. U. Ahmed

This study shows IL-8 promotes cellular plasticity and therapeutic resistance in glioblastoma by altering epigenetic marks and enhancing cancer initiating cell properties.

bioRxiv · Nov 16, 2018Cancer Biology